Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression.
about
Translational research of adult stem cell therapyClinical Trials of Adult Stem Cell Therapy in Patients with Ischemic StrokeCardiac stem cells: biology and clinical applicationsStem cells as drug delivery methods: application of stem cell secretome for regenerationCell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsPotential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart diseaseCardiac-derived stem cell-based therapy for heart failure: progress and clinical applicationsHypoxic preconditioning improves survival of cardiac progenitor cells: role of stromal cell derived factor-1α-CXCR4 axisLeft atrial appendages from adult hearts contain a reservoir of diverse cardiac progenitor cellsAdult Stem Cell Therapy for Stroke: Challenges and ProgressStem Cell Therapy for the Heart: Blind Alley or Magic Bullet?CXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in miceInhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: improving the safety of iPS cell transplantation to myocardiumCXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activitymicroRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4.Enhancement of cell-based therapeutic angiogenesis using a novel type of injectable scaffolds of hydroxyapatite-polymer nanocomposite microspheresContrasting roles of E2F2 and E2F3 in cardiac neovascularization.Stem cell therapy: pieces of the puzzle.Individual fates of mesenchymal stem cells in vitro.Multimodal Hydrogel-Based Platform To Deliver and Monitor Cardiac Progenitor/Stem Cell Engraftment.Exosomes: Fundamental Biology and Roles in Cardiovascular PhysiologyMyocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction.Local activation of cardiac stem cells for post-myocardial infarction cardiac repairPreconditioning stem cells for in vivo delivery.The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injuryEmpowering adult stem cells for myocardial regenerationExpression of a Distinct Set of Chemokine Receptors in Adipose Tissue-Derived Stem Cells is Responsible for In Vitro Migration Toward Chemokines Appearing in the Major Pelvic Ganglion Following Cavernous Nerve Injury.Genetic engineering of mesenchymal stem cells and its application in human disease therapy.Intracoronary delivery of bone-marrow-derived stem cells.Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts.Targeted migration of mesenchymal stem cells modified with CXCR4 to acute failing liver improves liver regenerationDelayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.Transfusion of CXCR4-primed endothelial progenitor cells reduces cerebral ischemic damage and promotes repair in db/db diabetic miceRehmannia glutinosa extract activates endothelial progenitor cells in a rat model of myocardial infarction through a SDF-1 α/CXCR4 cascadeWnt1 inhibits hydrogen peroxide-induced apoptosis in mouse cardiac stem cellsUpregulation of stromal cell-derived factor 1 (SDF-1) is associated with macrophage infiltration in renal ischemia-reperfusion injury.Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury.Rosuvastatin enhances angiogenesis via eNOS-dependent mobilization of endothelial progenitor cells.Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarction
P2860
Q26774565-1EA64451-667A-4FA0-A584-66D5BFDE3347Q26776494-80CE2865-0AD6-4350-97D9-61AF7D64E156Q26825051-20B4A584-0848-40F7-B44A-C37F0C000A4AQ26862657-F113FDE2-7D34-4B44-B3E4-AD606580F1F4Q27001159-47DFC911-C8B3-4CDD-9731-03700E43F378Q27012551-A51CB91C-E291-497F-A2AA-C91013F5C438Q27025973-18CD9A3B-5B43-4C5E-929B-131F3C6B188FQ27302080-92E40359-18AB-403D-AC86-9CA2BA2B396DQ27334201-2CD2F0C9-DDEE-4AC4-95A3-7EB5B4F68F72Q28066235-49AECD93-009F-4ECB-87E1-00100B6FD26CQ28069300-173DACA7-005A-499C-BA7B-6A7C1067AFB5Q28254272-92E67DD5-34A6-429E-868B-6ADEF9CC9492Q28305306-ED901E9B-F73F-4E02-9A24-6C37BBC81259Q28587353-C72C0DC9-99BD-469D-93C8-4E63375B8308Q31039862-E796D51D-3EC0-4FE4-B090-7F59A4B2192BQ31058133-2B7F4FB1-762E-435F-88F2-2A3FC84A7A53Q31120422-6A54CE3A-E402-48B0-A3C3-CA8982FE02A3Q33348580-432AB0CD-1359-475C-B4EC-FDFDC9970AB6Q33589320-0A3A12E3-F65E-44C0-AB40-48EF863D38A8Q33612426-31C43F72-3F45-4CF8-86ED-825460DF175AQ33657616-1E42D791-9798-4585-BCA9-A129A5F343FDQ33746524-27CC34FA-D82B-4BBB-AA23-5BD59947BA21Q33951374-31BE79F7-D078-45A7-A140-E653CCD09E8BQ33985922-F1A28D0B-77A1-41AB-9C6F-081905D8CEECQ33998015-1C632298-999E-42B7-919B-1C0120E1BBB7Q34236827-33554EB2-BC91-41C9-8CC2-23B895DBBEADQ34239856-49E6CDE5-F134-4D81-A703-FFADD244D0F7Q34286884-2F76EB50-54AB-4181-AEDE-466FA3D4A871Q34298871-F61282A3-5225-45D6-B11A-0391B9FD7B2CQ34318046-2999E9D4-5DA1-4C9C-967C-EDAC7AF23C0DQ34357646-0FFFE394-0838-4121-862B-C2255F6DC662Q34405145-D1650D2F-8731-477E-9D9D-E885F7A8C52DQ34432396-64E4C1D9-93AF-44B2-A68B-E56D2EB7D333Q34491057-8B049036-427E-4B34-88EA-822B6D935BCFQ34562890-C12AEBEA-9C09-497C-A8F1-B83DDDC9EDA2Q34637692-6583D23D-0578-4DFE-A4AA-8B44F3788006Q34640766-4A73A959-1033-4844-9929-42CAEAAF5205Q34720770-E9C87366-3286-42DD-88BF-D19AD53AA662Q34737352-E7A50078-793A-422A-9E56-7C245B74F836Q34956358-81FA09DF-67AC-408C-898E-F7CBAFDFF6CE
P2860
Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hypoxic preconditioning enhanc ...... by inducing CXCR4 expression.
@en
Hypoxic preconditioning enhanc ...... by inducing CXCR4 expression.
@nl
type
label
Hypoxic preconditioning enhanc ...... by inducing CXCR4 expression.
@en
Hypoxic preconditioning enhanc ...... by inducing CXCR4 expression.
@nl
prefLabel
Hypoxic preconditioning enhanc ...... by inducing CXCR4 expression.
@en
Hypoxic preconditioning enhanc ...... by inducing CXCR4 expression.
@nl
P2093
P2860
P1433
P1476
Hypoxic preconditioning enhanc ...... by inducing CXCR4 expression.
@en
P2093
Douglas W Losordo
Gangjian Qin
John Zhang
Lijuan Chen
M Ian Phillips
Raj Kishore
Wuqiang Zhu
Yao Liang Tang
P2860
P304
P356
10.1161/CIRCRESAHA.109.197723
P577
2009-04-30T00:00:00Z